NIS to observe improvement in global assessment of functioning in patients with schizophrenia
Study identifier:NIS-NSI-SER-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Non-interventional clinical study to observe improvement in global assessment of functioning in patients with schizophrenia, treated with atypical antipsychotics
Medical condition
schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
106
Study type
Observational
Age
18 Years - 80 Years
Date
Study Start Date: 01 Feb 2009
Primary Completion Date: 01 Nov 2010
Study Completion Date: 01 Nov 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Seroquel SR: Patients whose symptoms are controlled with Seroquel SR and started with the therapy up to 1 month before the inclusion | - |
| 2 Atypical antipsychotics: Patients whose symptoms are controlled with atypical antipsychotic in once daily formulation (excluding Seroquel SR) and started with the therapy up to 1 month before the inclusion | - |
Contacts
Investigators
Principal Investigator
Peter Pregelj
Psihiatricna klinika Ljubljana, Studenec 48, 1260 Ljubljana
